Medications have long been used to treat pain but most of them are short-term fixes and can cause side effects. Researchers at the University of Missouri have discovered a new compound, boronicaine that could potentially have longer-lasting effects and could even act as an anesthetic alternative.
"Because of its versatility and effectiveness at quickly numbing pain in targeted areas, lidocaine has been the gold standard in local anesthetics for more than 50 years. While lidocaine is effective as a short-term painkiller, its effects wear off quickly. We developed a new compound that can quickly provide longer lasting relief," said lead author of the study George Kracke, associate professor at University of Missouri.
Opioid Painkillers Carry High Risk of Death
Opioid painkillers carry higher risk of death, overdose, addiction or serious side effects than benefits in chronic, non-cancer conditions like headache, fibromyalgia and chronic low back pain.
Advertisement
Researchers changed the chemical structure of lidocaine and found that the new compound provided pain relief that lasted five minutes longer than lidocaine.
In pre-clinical studies, boronicaine offered 25 minutes pain relief, compared to five minutes of pain relief with lidocaine.
Lidocaine is an injectable pain reliever used in minor surgical or dental procedures, or as a topical ointment or spray to relieve itching, burning and pain from shingles, sunburns, jellyfish stings and insect bites.
![Over-the-Counter Painkillers can Help Avoid Marijuana-Induced Learning and Memory Problems]( "Over-the-Counter Painkillers can Help Avoid Marijuana-Induced Learning and Memory Problems")
Researchers have identified the molecular pathways that are responsible for marijuana-induced learning and memory problems.
Boronicaine could also potentially serve many of those same functions as an injectable or topical painkiller.
"Although some conditions may warrant the use of a short-lasting painkiller, in many cases a longer lasting anesthetic is a better option. Having a longer lasting anesthetic reduces the dosage or number of doses needed, limiting the potential for adverse side effects," Kracke said.
The findings were detailed in the journal ChemMedChem.
Source: Medindia
Lidocaine is an injectable pain reliever used in minor surgical or dental procedures, or as a topical ointment or spray to relieve itching, burning and pain from shingles, sunburns, jellyfish stings and insect bites.
Over-the-Counter Painkillers can Help Avoid Marijuana-Induced Learning and Memory Problems
Researchers have identified the molecular pathways that are responsible for marijuana-induced learning and memory problems.
Advertisement
Boronicaine could also potentially serve many of those same functions as an injectable or topical painkiller.
"Although some conditions may warrant the use of a short-lasting painkiller, in many cases a longer lasting anesthetic is a better option. Having a longer lasting anesthetic reduces the dosage or number of doses needed, limiting the potential for adverse side effects," Kracke said.
The findings were detailed in the journal ChemMedChem.
Source: Medindia
Mechanism That Prevents Transmission of Pain Signals to Brain can Lead to Development of New Painkiller Drugs
Researchers have discovered an analgesic mechanism which limits the transmission of pain signals to the brain among patients with Buruli ulcer.
Advertisement
 Music-The Natural PainkillerAround 40 percent of people claim that listening to music helped them alleviate pain, according to a new survey | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
Lilly will likely maintain or increase its market share in the insulin space as the average out-of-pocket cost for its insulin products is already below the $35 price cap.
In myeloma (blood cancer) cells, cancer-promoting potential of the fatty acid binding proteins was found to determine to be a valid target for myeloma therapeutics
Acute liver failure cases dropped after the Food and Drug Administration rule to lower the dosage of acetaminophen